NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
10/31/2023
Back to search
Official data from USPTO
DXM PHARMACEUTICAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
31
Latest update
10/31/2023
Trademark type
Combined
Nice classes
5
Filing date
07/11/2017
Registration date
05/01/2018
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
10/31/2023
Last transaction
10/31/2023
Responsible office
United States Patent and Trademark Office
Status code
702
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
02/08/2018
First use in commerce
02/08/2018
Drawing code
3
Owner type
03
Owner location
Houston, TX
Examiner
ANKRAH, NAAKWAMA
Law office
L90
Current location
TMEG LAW OFFICE 109
Mark description
The mark consists of a "DXM" design over the word "PHARMACEUTICAL", where the "DXM" design includes a letter "D" in shades of blue, a letter "X" including a depiction of splashing liquid in shades of red, and a letter "M" including a depiction of splashing liquid in shades of blue, and where the word "PHARMACEUTICAL" is in grey.
Holders and representatives
Holders
DXM Pharmaceutical, Inc.
Representatives
Keith B. Willhelm ATTORNEY AT LAW
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical preparationsover-the-counter cough syrups
Publications
History of USPTO decisions and trademark events.
31 publications found
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
10/31/2023
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
10/31/2023
E815
TEAS SECTION 8 & 15 RECEIVED
05/01/2023
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
05/01/2023
R.PR
REGISTERED-PRINCIPAL REGISTER
05/01/2018
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
03/27/2018
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
03/26/2018
SUPC
STATEMENT OF USE PROCESSING COMPLETE
03/16/2018
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
03/16/2018
IUAF
USE AMENDMENT FILED
02/27/2018
EISU
TEAS STATEMENT OF USE RECEIVED
02/27/2018
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
02/06/2018
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/05/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/12/2017
PUBO
PUBLISHED FOR OPPOSITION
12/12/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/22/2017
ALIE
ASSIGNED TO LIE
11/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/26/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/25/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/25/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
10/25/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
10/16/2017
GNRT
NON-FINAL ACTION E-MAILED
10/16/2017
CNRT
NON-FINAL ACTION WRITTEN
10/16/2017
DOCK
ASSIGNED TO EXAMINER
10/10/2017
MDSC
NOTICE OF DESIGN SEARCH CODE E-MAILED
07/18/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/17/2017
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/17/2017
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/17/2017
NWAP
NEW APPLICATION ENTERED
07/14/2017
Continuous trademark protection
Get notified about every new filing that threatens DXM PHARMACEUTICAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.